wegovy liver disease - Search News

Order byBest matchMost fresh

News

Wegovy, Novo Nordisk and fatty liver disease

· 2d · on MSN

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s blockbuster Wegovy medicine to treat a serious fatty liver disease. Shares in Novo Nordisk rose as much as 5% in early European trading Monday,

Continue reading

Managed Healthcare Executive · 2d

FDA Grants Accelerated Approval of Wegovy to Treat Liver Disease

· 2d · on MSN

Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease

Fierce Pharma2d

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

BioPharma Dive2d

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

FDA Approval Expands Novo Nordisk’s Wegovy to the Fatty Liver Disease MASH

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

4don MSN

Novo Nordisk’s Wegovy Gets US Approval for Liver Disease

Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy received Food and Drug Administration approval to treat a serious form ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results